Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.

@article{Graeser2009ContralateralBC,
  title={Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.},
  author={Monika K Graeser and Christoph Engel and Kerstin Rhiem and Dorothea Gadzicki and Ulrich Bick and Karin Kast and Ursula G. Froster and Bettina Schlehe and Astrid Bechtold and N Onyango Arnold and Sabine Preisler-Adams and Carolin Nestle-Kraemling and Mohammad Zaino and Markus Loeffler and Martin Kiechle and Alfons Meindl and Dominik Varga and Rita Katharina Schmutzler},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2009},
  volume={27 35},
  pages={
          5887-92
        }
}
PURPOSE To estimate the risk for contralateral breast cancer in members of BRCA1- and BRCA2-positive families and to determine predictive risk factors. PATIENTS AND METHODS A retrospective, multicenter, cohort study was performed from 1996 until 2008 and comprised 2,020 women with unilateral breast cancer (index patients, n = 978; relatives, n = 1.42) from 978 families who had a BRCA1 or BRCA2 mutation. Cox regression analysis was applied to assess the association of age at first breast… CONTINUE READING

Figures, Tables, and Topics from this paper.

Explore Further: Topics Discussed in This Paper

Citations

Publications citing this paper.
SHOWING 1-10 OF 128 CITATIONS, ESTIMATED 45% COVERAGE

Recent BRCAPRO upgrades significantly improve calibration.

  • Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • 2014
VIEW 7 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

[Controlateral prophylactic mastectomy: on which arguments?].

  • Gynecologie, obstetrique & fertilite
  • 2013
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Predictors of Contralateral Breast Cancer in BRCA Negative Women

VIEW 8 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2016
VIEW 6 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ

  • Molecular genetics & genomic medicine
  • 2019
VIEW 1 EXCERPT
CITES BACKGROUND

FILTER CITATIONS BY YEAR

2010
2019

CITATION STATISTICS

  • 8 Highly Influenced Citations

  • Averaged 8 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 17 REFERENCES

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2008
VIEW 2 EXCERPTS

Survival and prognostic factors in BRCA1-associated breast cancer.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2006

Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2006
VIEW 3 EXCERPTS

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers.

  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2004
VIEW 1 EXCERPT